Osler Diagnostics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
130
- Latest Deal Type
-
Later Stage VC
- (Upcoming)
- Investors
-
14
Osler Diagnostics General Information
Description
Developer of a blood sampling and testing device designed to test for biomarkers. The company's diagnostic device is capable of taking a drop of blood and testing for a panel of biomarkers accurately, with applicability to a large number of biomarkers, enabling healthcare providers to have access to decentralized diagnostics and conduct tests for health markers of interest.
Contact Information
Website
www.oslerdiagnostics.comCorporate Office
- King Charles House
- Park End Street
- Oxford OX1 1JD
- England, United Kingdom
Corporate Office
- King Charles House
- Park End Street
- Oxford OX1 1JD
- England, United Kingdom
Osler Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC | Upcoming | Product Development | ||||
| 11. Later Stage VC (Series C) | 25-Oct-2022 | Completed | Product Development | |||
| 10. Grant | 01-Apr-2022 | Completed | Product Development | |||
| 9. Grant | 01-Oct-2021 | Completed | Product Development | |||
| 8. Early Stage VC (Series B) | 20-Nov-2020 | Completed | Product Development | |||
| 7. Grant | 01-Jun-2020 | Completed | Product Development | |||
| 6. Early Stage VC (Series A) | 01-Mar-2019 | Completed | Product Development | |||
| 5. Grant | 01-Nov-2018 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2018 | $140K | $7.29M | Completed | Generating Revenue | |
| 3. Seed Round | 23-Aug-2017 | $4.55M | $7.29M | Completed | Generating Revenue |
Osler Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C Preference | ||||||||
| Series B Preference | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 166,666 | $0.011154 | $23.42 | $23.42 | 1x | $23.42 | 15.2% | |
| Ordinary | 138,131 | $0.011154 | $16.73 | $16.73 | 1x | $16.73 | 12.6% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Osler Diagnostics Comparisons
Industry
Financing
Details
Osler Diagnostics Competitors (3)
One of Osler Diagnostics’s 3 competitors is Werfen, a Private Debt Financed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Werfen | Private Debt Financed | Barcelona, Spain | ||||
| Roche Diagnostics | Corporation | Rotkreuz, Switzerland | ||||
| Abbott Diagnostics | Failed Transaction (M&A) | Lake Forest, IL |
Osler Diagnostics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Osler Diagnostics Patents
Osler Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024405495-A1 | Haematocrit and haemoglobin detection method and system | Pending | 22-Dec-2023 | ||
| EP-4816821-A1 | Haematocrit and haemoglobin detection method and system | Pending | 22-Dec-2023 | ||
| GB-202319902-D0 | Haematocrit and haemoglobin detection method and system | Inactive | 22-Dec-2023 | ||
| WO-2025131856-A1 | Haematocrit and haemoglobin detection method and system | Inactive | 22-Dec-2023 | ||
| AU-2024390465-A1 | Liquid collection device and liquid handling device configured to receive a liquid collection device | Pending | 30-Nov-2023 | A61B5/150022 |
Osler Diagnostics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Osler Diagnostics Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fushia Investments | Venture Capital | Minority | ||
| Leedon Park | PE/Buyout | Minority | ||
| M&G | Asset Manager | Minority | ||
| Braavos Investment Advisers | Venture Capital | Minority | ||
| Lansdowne Partners | Asset Manager | Minority |
Osler Diagnostics FAQs
-
When was Osler Diagnostics founded?
Osler Diagnostics was founded in 2016.
-
Where is Osler Diagnostics headquartered?
Osler Diagnostics is headquartered in Oxford, United Kingdom.
-
What is the size of Osler Diagnostics?
Osler Diagnostics has 130 total employees.
-
What industry is Osler Diagnostics in?
Osler Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Osler Diagnostics a private or public company?
Osler Diagnostics is a Private company.
-
What is Osler Diagnostics’s current revenue?
The current revenue for Osler Diagnostics is .
-
How much funding has Osler Diagnostics raised over time?
Osler Diagnostics has raised $187M.
-
Who are Osler Diagnostics’s investors?
Fushia Investments, Leedon Park, M&G, Braavos Investment Advisers, and Lansdowne Partners are 5 of 14 investors who have invested in Osler Diagnostics.
-
Who are Osler Diagnostics’s competitors?
Werfen, Roche Diagnostics, and Abbott Diagnostics are competitors of Osler Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
